BRONJ In A Patient with Rheumatoid Arthritis: An Unnamed Association

Yusuf Ziya Şener*¹ Burak Yasin Aktaş¹, Levent Kılıç², Ahmet Çağkan İnkaya³ and Umut Kalyoncu²

DOI: 10.26717/BJSTR.2017.01.000198

Received: July 10, 2017;   Published: July 18, 2017

To view the Full Article   Peer-reviewed Article PDF

Abstract

Bisphosphonates (BPs) are important drugs in treatment and prevention of all types of osteoporosis. BRONJ is a well known complication of BP treatment since 2002 when it was firstly described. Although most of the reported cases are patients with malignancies. Rheumatoid arthritis is a well known risk factor for BRONJ. In this report, we present a patient with BRONJ who was in our follow up due to rheumatoid arthritis.

Introduction| Case Report| Discussion| Conclusion| References|